Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

The present study was performed to investigate the effects of single or combined administration of galactooligosaccharide (GOS) and Pediococcus acidilactici on cutaneous mucus immune parameters, humoral immune responses and immune related genes expression in common carp (Cyprinus carpio) fingerlings. Carps were fed experimental diets for 8 weeks as follows: non-supplemented (Control), prebiotic diet (10 g/kg GOS), probiotic diet (1 g/kg [0.9 × 107 CFU] lyophilized P. acidilactici) and synbiotic diet (10 GOS in combination with 1 g/kg [0.9 × 107 CFU] lyophilized P. acidilactici). Unlike skin mucus, the serum lysozyme activity showed no significant difference between carps fed supplemented or control diets, however, remarkable elevation of serum ACH50 activity was noticed in carps fed supplemented diet (pro-, pre- and synbiotic diets) compared control group. Besides, feeding on pro-, pre- and synbiotic supplemented diets significantly increased serum and skin mucus total Ig levels. However, no significant difference was observed between treatments and control group in case of skin mucus proteases activity. There was no significant difference between expression levels of intestinal genes of LYZ and IL1b in fish fed on pre- and synbiotic, compared to the control. However, evaluation of TNF-alpha gene expression in the intestine of carps revealed remarkable down-regulation in treated groups (p < 0.05). These results indicated positive effect of supplementation of carp diet with GOS and P. acidilactici on some mucosal or serum immune parameters.

Keywords: Common carp; Galactooligosaccharide; Gene expression; Mucosal immune parameters; Probiotic; Synbiotic.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Pediococcus acidilacticiElevated Serum Total Ig LevelsBeneficial
Moderate
Pediococcus acidilacticiEnhanced Serum ACH50 ActivityBeneficial
Moderate
Pediococcus acidilacticiIncreased Serum Lysozyme ActivityNeutral
Small
Pediococcus acidilacticiNo Change in Skin Mucus Protease ActivityNeutral
Small
Pediococcus acidilacticiReduced TNF-Alpha ExpressionBeneficial
Large
Pediococcus acidilactici KABP™-021Elevated Serum Total Ig LevelsBeneficial
Moderate
Pediococcus acidilactici KABP™-021Enhanced Serum ACH50 ActivityBeneficial
Moderate
Pediococcus acidilactici KABP™-021Increased Skin Mucus IgG LevelsBeneficial
Moderate
Pediococcus acidilactici KABP™-021Reduced TNF-alpha Gene ExpressionBeneficial
Moderate
Pediococcus acidilactici MAK92P26AEnhanced Serum ACH50 ActivityBeneficial
Moderate
Pediococcus acidilactici MAK92P26AImproved Immune ResponseBeneficial
Moderate
Pediococcus acidilactici MAK92P26AReduced TNF-alpha Gene ExpressionBeneficial
Moderate
Pediococcus acidilactici R1001Elevated Serum Total Ig LevelsBeneficial
Moderate
Pediococcus acidilactici R1001Enhanced Serum ACH50 ActivityBeneficial
Moderate
Pediococcus acidilactici R1001Increased Serum Lysozyme ActivityNeutral
Small
Pediococcus acidilactici R1001Increased Skin Mucus IgG LevelsBeneficial
Moderate
Pediococcus acidilactici R1001No Change in Skin Mucus Protease ActivityNeutral
Small
Pediococcus acidilactici R1001Reduced Intestinal TNF-alpha Gene ExpressionBeneficial
Moderate
Pediococcus acidilactici VPro29Enhanced Serum ACH50 ActivityBeneficial
Moderate
Pediococcus acidilactici VPro29Reduced TNF-alpha Gene Expression in IntestineBeneficial
Moderate
Back to top